Washington, DC, United States of America

Dean H Hamer


Average Co-Inventor Count = 2.6

ph-index = 3

Forward Citations = 51(Granted Patents)


Company Filing History:


Years Active: 1984-1987

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Dean H. Hamer: Innovator in Biotechnology

Introduction

Dean H. Hamer is a prominent inventor based in Washington, DC. He has made significant contributions to the field of biotechnology, particularly in the development of recombinant DNA technologies. With a total of 3 patents, Hamer's work has had a lasting impact on medical research and applications.

Latest Patents

Hamer's latest patents include innovative approaches to encoding hepatitis B surface antigens. One notable patent describes a recombinant DNA vector that incorporates a promoter for a eukaryotic metallothionein gene, ligated to a gene sequence encoding the hepatitis B surface antigen. This vector also includes at least 69% of the transforming region of the bovine papilloma genome, allowing for controlled expression of the antigen. Another significant patent involves the use of an E. Coli plasmid SV40 vector recombinant, which is cloned to a gene of interest and amplified in bacteria. This SV40 vector can be introduced into eukaryotic cells, enabling the gene of interest to produce its protein product.

Career Highlights

Throughout his career, Hamer has worked with various organizations, including the United States of America as represented by the Department of Health. His work has been instrumental in advancing the understanding and treatment of viral infections.

Collaborations

Hamer has collaborated with notable colleagues such as John L. Gerin and Marian Kaehler. These partnerships have contributed to the success of his research and innovations.

Conclusion

Dean H. Hamer's contributions to biotechnology and his innovative patents have significantly advanced the field. His work continues to influence medical research and applications, showcasing the importance of innovation in addressing health challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…